Page 35 - Sanket Koul

Nationwide doctor strike against Kolkata rape-murder hits services

Protests by doctors demanding justice and better workplace security began in Kolkata and eventually spread to other parts of the country

Patient influx, test volumes raise Metropolis Healthcare's profit by 31%

Commenting on the results, Ameera Shah, Executive Chairperson and Whole-time Director, Metropolis Healthcare, said that the company has consistently achieved high growth in patient volume

Clinical trial waiver only if drugs have greater benefits, says govt

A senior official in the health ministry said that the rule will help to make available essential drugs that have a significant therapeutic advance over the current standard care

Separate marketing code: Medical devices industry welcomes govt's move

A separate marketing practices code has been a long-standing demand for medical devices. Currently, the industry has to comply with the marketing practices code for pharmaceuticals

Dr Lal PathLabs Q1 results: Net profit up by 29.1%, revenue rises by 11.3%

The company's revenue from operations rose to Rs 602 crore in Q1FY25, an 11.3 per cent Y-o-Y growth from Rs 541 crore reported in Q1FY24

Indian pharma market registers over 6% growth in July '24: Pharmarack

"Seasonality-driven molecules and molecular combinations, especially anti-infectives, have shown a relatively stronger volume-driven growth," the firm stated in its report

India's tryst with heart-breaking fourth-place finishes at the Olympics

With just four days for the closing ceremony of the Paris Games, India stares at the possibility of returning home with few medals

Fortis Healthcare Q1 results: Profit rises 40% over hospital biz growth

The company's revenue from operations rose to Rs 1,859 crore in Q1FY25, a 12.2 per cent Y-o-Y rise from Rs 1,657 crore reported in Q1FY24

Gland Pharma Q1 FY25 results: Net profit falls 26%, revenue rises 16%

The decrease in the group's consolidated Ebitda margin is being attributed to the negative Ebitda reported by Cenexi, its recent acquisition

Kerala, Tamil Nadu see fewer hospital admissions under Ayushman Bharat

The lesser numbers in Telangana are due to the presence of the state's own health insurance scheme for the poor, 'Aarogyasri,' which later merged with AB-PMJAY only in 2021

SC says no major breach in NEET-UG, raises concerns over NTA's exam conduct

Asks Centre's high-level committee to review NTA's ops and recommend reforms

Govt agencies conducting risk-based inspections of pharma units: Nadda

Over 400 drug manufacturing units, including MSMEs, inspected after high frequency of NQS reports

GSK Pharma Q1 FY25 results: Net profit rises 37%, revenue up 6.9%

GSK Pharma's stocks were up by 2.49 per cent, ending the day's trade at Rs 2,824.45 apiece on the Bombay Stock Exchange (BSE)

Sun Pharma Q1 results: Profit zooms 40% on robust global specialty sales

On a sequential basis, the company exhibited a 6.8 per cent rise in net profit, while its revenue grew by 5.5 per cent, from Rs 2,655 crore and Rs 12,380.7 crore reported in Q3 FY24, respectively

Max Healthcare Q1 results: Net profit drops 1.6%, revenue up by 20%

Max to invest Rs 230 crore to set up 250 bed hospital in Mohali

Mankind Pharma Q1 results: Profit up 9.9% at Rs 543 cr; revenue rises 12%

Mankind also announced a rise in its prescriber penetration to 83.2 per cent in Q1 FY25, from 82.7 per cent in the same quarter last financial year

Paris Olympics 2024: With Bronze medals, shooting stars over the moon

Manu has become the first Indian to win two medals in the same edition of the Olympic Games after Independence

Rare disease patients suffer as CoEs under-utilise funds, shows data

5 of 12 CoEs formed to treat rare diseases have spent less than 35% funds allotted

10 bagless days for classes 6-8: NCERT makes schools stress-free

The guidelines add that these bagless days will be encouraged throughout the year for various types of enrichment activities involving arts, quizzes, sports and vocational crafts

Mankind Pharma to lead in Indian women's health market after BSV deal

Deal opens doors to overseas markets with low competition